Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Daniela Femminella¹, Eleni Frangou², Sharon B Love², Gail Busza¹, Clive Holmes³, Craig Ritchie¹, Robert Lawrence⁴, Brady McFarlane³, George Tadros⁵, Basil H Ridha⁶, Carol Bannister⁷, Zuzana Walker⁸, Hilary Archer⁹, Elizabeth Coulthard⁹, Ben R Underwood¹⁰, Aparna Prasanna¹¹, Paul Koranteng¹², Salman Karim¹³, Kehinde Junaid¹⁴, Bernadette McGuinness¹⁵, Ramin Nilforooshan¹⁶, Ajay Macharouthu¹⁷, Andrew Donaldson¹⁸, Simon Thacker¹⁹, Gregor Russell²⁰, Naghma Malik²¹, Vandana Mate²², Lucy Knight²³, Sajeev Kshemendran²⁴, John Harrison^{25

26}, Christian Hölscher²⁷, David J Brooks^{1

28}, Anthony Peter Passmore¹⁵, Clive Ballard⁷, Paul Edison^{29

30}

Affiliations

¹ Department of Medicine, Imperial College London, London, UK.
² Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
³ Southern Health NHS Foundation Trust, Havant, UK.
⁴ SW London and St George's Mental Health Trust, London, UK.
⁵ Aston Medical school, Aston University, Birmingham, UK.
⁶ Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
⁷ South London and Maudsley NHS Foundation Trust, London, UK.
⁸ University College London and Essex Partnership University NHS Foundation Trust, Runwell, UK.
⁹ North Bristol NHS Trust, Bristol, UK.
¹⁰ Cambridgeshire and Peterborough NHS Foundation Trust, Peterborough, UK.
¹¹ Black Country Partnership NHS Foundation Trust, West Bromwich, UK.
¹² Northamptonshire Healthcare NHS Foundation Trust, Kettering, UK.
¹³ Lancashire Care NHS Foundation Trust, Preston, UK.
¹⁴ Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK.
¹⁵ Centre for Public Health, Queen's University Belfast, Belfast, UK.
¹⁶ Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, UK.
¹⁷ NHS Ayrshire and Arran, Crosshouse, UK.
¹⁸ NHS Lanarkshire, Glasgow, UK.
¹⁹ Derbyshire Healthcare NHS Foundation Trust, Derby, UK.
²⁰ Bradford District Care NHS Foundation Trust, Bradford, UK.
²¹ 5 Boroughs Partnership NHS Foundation Trust, Warrington, UK.
²² Cornwall Partnership NHS Foundation Trust, Redruth, UK.
²³ Somerset Partnership NHS Foundation Trust, Bridgwater, UK.
²⁴ South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Stafford, UK.
²⁵ Alzheimer Center VUmc Amsterdam, Amsterdam, the Netherlands.
²⁶ Institute of Psychiatry, Psychology & Neuroscience King's College London, London, UK.
²⁷ Research Department, Henan University of Chinese Medicine, Zhengzhou, China.
²⁸ Newcastle University, Newcastle upon Tyne, UK.
²⁹ Department of Medicine, Imperial College London, London, UK. paul.edison@imperial.ac.uk.
³⁰ School of Medicine, College of Biomedical and Life sciences, Cardiff University, Cardiff, CF14 4YS, UK. paul.edison@imperial.ac.uk.

PMID: 32684162
PMCID: PMC7370449
DOI: 10.1186/s13063-020-04608-4

Published Erratum

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Daniela Femminella et al. Trials. 2020.

. 2020 Jul 19;21(1):660.

doi: 10.1186/s13063-020-04608-4.

Authors

Affiliations

¹ Department of Medicine, Imperial College London, London, UK.
² Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
³ Southern Health NHS Foundation Trust, Havant, UK.
⁴ SW London and St George's Mental Health Trust, London, UK.
⁵ Aston Medical school, Aston University, Birmingham, UK.
⁶ Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
⁷ South London and Maudsley NHS Foundation Trust, London, UK.
⁸ University College London and Essex Partnership University NHS Foundation Trust, Runwell, UK.
⁹ North Bristol NHS Trust, Bristol, UK.
¹⁰ Cambridgeshire and Peterborough NHS Foundation Trust, Peterborough, UK.
¹¹ Black Country Partnership NHS Foundation Trust, West Bromwich, UK.
¹² Northamptonshire Healthcare NHS Foundation Trust, Kettering, UK.
¹³ Lancashire Care NHS Foundation Trust, Preston, UK.
¹⁴ Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK.
¹⁵ Centre for Public Health, Queen's University Belfast, Belfast, UK.
¹⁶ Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, UK.
¹⁷ NHS Ayrshire and Arran, Crosshouse, UK.
¹⁸ NHS Lanarkshire, Glasgow, UK.
¹⁹ Derbyshire Healthcare NHS Foundation Trust, Derby, UK.
²⁰ Bradford District Care NHS Foundation Trust, Bradford, UK.
²¹ 5 Boroughs Partnership NHS Foundation Trust, Warrington, UK.
²² Cornwall Partnership NHS Foundation Trust, Redruth, UK.
²³ Somerset Partnership NHS Foundation Trust, Bridgwater, UK.
²⁴ South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Stafford, UK.
²⁵ Alzheimer Center VUmc Amsterdam, Amsterdam, the Netherlands.
²⁶ Institute of Psychiatry, Psychology & Neuroscience King's College London, London, UK.
²⁷ Research Department, Henan University of Chinese Medicine, Zhengzhou, China.
²⁸ Newcastle University, Newcastle upon Tyne, UK.
²⁹ Department of Medicine, Imperial College London, London, UK. paul.edison@imperial.ac.uk.
³⁰ School of Medicine, College of Biomedical and Life sciences, Cardiff University, Cardiff, CF14 4YS, UK. paul.edison@imperial.ac.uk.

PMID: 32684162
PMCID: PMC7370449
DOI: 10.1186/s13063-020-04608-4

Abstract

An amendment to this paper has been published and can be accessed via the original article.

PubMed Disclaimer

Erratum for

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P. Femminella GD, et al. Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x. Trials. 2019. PMID: 30944040 Free PMC article.

References

1. Femminella, et al. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study) Trials. 2019;20:191. doi: 10.1186/s13063-019-3259-x. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Affiliations

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Authors

Affiliations

Abstract

Erratum for

References

Publication types

LinkOut - more resources

Full Text Sources